Hoaglin DC, Hawkins N, Jansen JP, Scott DA, Itzler R, Cappelleri JC, et al
Authors: V
After removing 398 duplicate articles, 691 articles were excluded based on screening of the titles and abstracts
Sagara M, Suzuki K, Aoki C, Tanaka S, Taguchi I, Inoue T, et al
However, some agents [including glucagon-like peptide (GLP)-1 receptor agonists and SGLT2 inhibitors] have already demonstrated benefits in populations without diabetes, and it is these agents, along with metformin, that hold out the most promise for further investigation in sarcopenia
"I thought I was doing things right with exercise and a balanced diet, but I was never, ever really satisfied with the weight management I was able to maintain on my own," Salberg told Business Insider